We observed no evidence of dominance at rs1800437 ( P = 0.16)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
Who should not take GLP-1s GLP-1s in all forms are unsuitable for people who: are pregnant or breastfeeding do not meet the eligibility criteria have a family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) Medical Perspective Patients with needle phobia, a preference for pill-based routines, or good adherence to oral administration guidelines may be better suited to oral GLP-1 formulations like semaglutide (Rybelsus, Wegovy), which can enhance treatment acceptance and potentially offer strong glycemic or weight control
Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I
Validated assay content: 10.26 mg with purity greater than 99.8 percent
Quick Notables Collaborations, launches, and other tidbits to keep on your radar